Literature DB >> 8777897

Fyn tyrosine kinase is required for normal amygdala kindling.

D P Cain1, S G Grant, D Saucier, E L Hargreaves, E R Kandel.   

Abstract

To identify specific genes involved with epileptogenesis kindling was examined in mice carrying mutations engineered by gene targeting. Amygdala kindling was tested in mice with a null-mutation in the Fyn tyrosine kinase gene, a mutation that raises the threshold for the induction of long-term potentiation in the hippocampus. The fyn mutants had a normal threshold, duration and stability of epileptiform after-discharge, which is crucial for kindling. Despite the normal after-discharge, fyn mutants showed a striking retardation in the rate of kindling. Once the kindled state was established in fyn mutants it remained stable. This implicates a Fyn-dependent biochemical pathway in the induction but not the maintenance of normal amygdala kindling. fyn is the first gene identified to be required for normal epileptogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8777897     DOI: 10.1016/0920-1211(95)00029-1

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

1.  Structural organization of the amygdaloid complex of the rat brain.

Authors:  L B Kalimullina; A V Akhmadeev; Z R Minibaeva; L R Mutalova
Journal:  Neurosci Behav Physiol       Date:  2004-07

2.  Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders.

Authors:  E M Kenny; P Cormican; S Furlong; E Heron; G Kenny; C Fahey; E Kelleher; S Ennis; D Tropea; R Anney; A P Corvin; G Donohoe; L Gallagher; M Gill; D W Morris
Journal:  Mol Psychiatry       Date:  2013-10-15       Impact factor: 15.992

3.  Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

Authors:  Erik D Roberson; Brian Halabisky; Jong W Yoo; Jinghua Yao; Jeannie Chin; Fengrong Yan; Tiffany Wu; Patricia Hamto; Nino Devidze; Gui-Qiu Yu; Jorge J Palop; Jeffrey L Noebels; Lennart Mucke
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

4.  AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.

Authors:  J Nicholas Cochran; Pauleatha V Diggs; N Miranda Nebane; Lynn Rasmussen; E Lucile White; Robert Bostwick; Joseph A Maddry; Mark J Suto; Erik D Roberson
Journal:  J Biomol Screen       Date:  2014-08-25

5.  A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus.

Authors:  P P Sanna; F Berton; M Cammalleri; M K Tallent; G R Siggins; F E Bloom; W Francesconi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice.

Authors:  N Kojima; H Ishibashi; K Obata; E R Kandel
Journal:  Learn Mem       Date:  1998 Nov-Dec       Impact factor: 2.460

7.  Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene.

Authors:  N Kojima; J Wang; I M Mansuy; S G Grant; M Mayford; E R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesis.

Authors:  Hal Blumenfeld; Angelika Lampert; Joshua P Klein; John Mission; Michael C Chen; Maritza Rivera; Sulayman Dib-Hajj; Avis R Brennan; Bryan C Hains; Stephen G Waxman
Journal:  Epilepsia       Date:  2008-07-14       Impact factor: 5.864

9.  Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.

Authors:  Shaunik Sharma; Steven Carlson; Sreekanth Puttachary; Souvarish Sarkar; Lucas Showman; Marson Putra; Anumantha G Kanthasamy; Thimmasettappa Thippeswamy
Journal:  Neurobiol Dis       Date:  2017-11-29       Impact factor: 5.996

Review 10.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.